Latest Breaking News On - Flem jacobsen - Page 1 : vimarsana.com

/PRNewswire/ Serca Pharmaceuticals, a cardioprotection company that is developing 13-M, a novel first-in-class treatment for minimising the tissue damage.

Noord hollandIvar sjaastadBrigitte lygrenJonas skogestadFlem jacobsenMagnus aronsenJo klavenessKjetil hestdalCentre molecular medicine norwayOslo university hospital ullevalEuropean society of cardiology congressNordic congressSerca pharmaceuticalsUniversity hospitalInstitute of pharmacyCancer research